title: PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells.
abstract: We have previously shown that Protein Kinase C delta (PKCδ) functions as a tumor promoter in non-small cell lung cancer (NSCLC), specifically in the context of K-ras addiction. Here we define a novel PKCδ -> integrin αVβ3 ->Extracellular signal-Regulated Kinase (ERK) pathway that regulates the transformed growth of K-ras dependent NSCLC cells. To explore how PKCδ regulates tumorigenesis, we performed mRNA expression analysis in four KRAS mutant NSCLC cell lines that stably express scrambled shRNA or a PKCδ targeted shRNA. Analysis of PKCδ-dependent mRNA expression identified 3183 regulated genes, 210 of which were specifically regulated in K-ras dependent cells. Genes that regulate extracellular matrix and focal adhesion pathways were most highly represented in this later group. In particular, expression of the integrin pair, αVβ3, was specifically reduced in K-ras dependent cells with depletion of PKCδ, and correlated with reduced ERK activation and reduced transformed growth as assayed by clonogenic survival. Re-expression of PKCδ restored ITGAV and ITGB3 mRNA expression, ERK activation and transformed growth, and this could be blocked by pretreatment with a αVβ3 function-blocking antibody, demonstrating a requirement for integrin αVβ3 downstream of PKCδ. Similarly, expression of integrin αV restored ERK activation and transformed growth in PKCδ depleted cells, and this could also be inhibited by pretreatment with PD98059.Our studies demonstrate an essential role for αVβ3 and ERK signalingdownstream of PKCδ in regulating the survival of K-ras dependent NSCLC cells, and identify PKCδ as a novel therapeutic target for the subset of NSCLC patients with K-ras dependent tumors.
authors.affiliation: Program in Cancer Biology, The Graduate School, Aurora, CO, USA.|Matrix and Morphogenesis Section, NIDCR, NIH, Bethesda, MD, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Symonds
authors.affiliation: The Department of Craniofacial Biology, School of Dental Medicine, Aurora, CO, USA.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Ohm
authors.affiliation: The Department of Medical Oncology, School of Medicine University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
authors.forename: Aik-Choon
authors.initials: AC
authors.lastname: Tan
authors.affiliation: The Department of Craniofacial Biology, School of Dental Medicine, Aurora, CO, USA.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Reyland
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism* / Q000473:pathology; D049109:Cell Proliferation / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000378:metabolism / Q000473:pathology; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000096:biosynthesis* / Q000378:metabolism; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D051745:Protein Kinase C-delta / Q000378:metabolism*; D016019:Survival Analysis; D014162:Transfection; D018631:ras Proteins / Q000378:metabolism*
chemical_list: D039302:Integrin alphaVbeta3; D051745:Protein Kinase C-delta; D018631:ras Proteins
keywords: KRAS; PKCδ; anchorage independent growth; integrins; lung cancer